Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
School-based head lice screening and oral ivermectin acceptability study
ACTRN12611000906954Phase 4Not yet recruiting
- Sponsor
- Australian National University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ivermectin in pediculosis capitis (4 arms), sponsored by Australian National University. Primary endpoint: Prevalence of head lice infestation after ivermectin program. Planned start Sep 2011; status: not yet recruiting.
02
Drugs
ivermectin
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on ACTRN12611000906954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000906954.